Literature DB >> 12619103

The UMD-p53 database: new mutations and analysis tools.

Christophe Béroud1, Thierry Soussi.   

Abstract

The tumor suppressor gene TP53 (p53) is the most extensively studied gene involved in human cancers. More than 1,400 publications have reported mutations of this gene in 150 cancer types for a total of 14,971 mutations. To exploit this huge bulk of data, specific analytic tools were highly warranted. We therefore developed a locus-specific database software called UMD-p53. This database compiles all somatic and germline mutations as well as polymorphisms of the TP53 gene which have been reported in the published literature since 1989, or unpublished data submitted to the database curators. The database is available at www.umd.necker.fr or at http://p53.curie.fr/. In this paper, we describe recent developments of the UMD-p53 database. These developments include new fields and routines. For example, the analysis of putative acceptor or donor splice sites is now automated and gives new insight for the causal role of "silent mutations." Other routines have also been created such as the prescreening module, the UV module, and the cancer distribution module. These new improvements will help users not only for molecular epidemiology and pharmacogenetic studies but also for patient-based studies. To achieve theses purposes we have designed a procedure to check and validate data in order to reach the highest quality data. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619103     DOI: 10.1002/humu.10187

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  50 in total

1.  The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53.

Authors:  Jose G Teodoro; Destin W Heilman; Albert E Parker; Michael R Green
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

Review 2.  New trends in molecular and cellular biomarker discovery for colorectal cancer.

Authors:  Parisa Aghagolzadeh; Ramin Radpour
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Statistical analysis of pathogenicity of somatic mutations in cancer.

Authors:  Chris Greenman; Richard Wooster; P Andrew Futreal; Michael R Stratton; Douglas F Easton
Journal:  Genetics       Date:  2006-06-18       Impact factor: 4.562

4.  Functional census of mutation sequence spaces: the example of p53 cancer rescue mutants.

Authors:  Samuel A Danziger; S Joshua Swamidass; Jue Zeng; Lawrence R Dearth; Qiang Lu; Jonathan H Chen; Jianlin Cheng; Vinh P Hoang; Hiroto Saigo; Ray Luo; Pierre Baldi; Rainer K Brachmann; Richard H Lathrop
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2006 Apr-Jun       Impact factor: 3.710

5.  New Phage Display-Isolated Heptapeptide Recognizing the Regulatory Carboxy-Terminal Domain of Human Tumour Protein p53.

Authors:  Sihem Ben Abid; Mouna Sahnoun; Ines Yacoubi-Hadj Amor; Salma Abdelmoula-Souissi; Hajer Hassairi; Raja Mokdad-Gargouri; Ali Gargouri
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

6.  Mortalin is a prognostic factor of gastric cancer with normal p53 function.

Authors:  Koji Ando; Eiji Oki; Yan Zhao; Ayae Ikawa-Yoshida; Hiroyuki Kitao; Hiroshi Saeki; Yasue Kimura; Satoshi Ida; Masaru Morita; Tetsuya Kusumoto; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2013-07-05       Impact factor: 7.370

7.  TP53 gene mutations are rare in nondysplastic Barrett's esophagus.

Authors:  Kamila Novotna; Marie Trkova; Alexandr Pazdro; Milan Smejkal; Alzbeta Soukupova; Daniela Kodetova; Premysl Smejkal; Zdenek Sedlacek
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 8.  At a glance: A history of autophagy and cancer.

Authors:  Xin Wen; Daniel J Klionsky
Journal:  Semin Cancer Biol       Date:  2019-11-07       Impact factor: 15.707

9.  Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Elizabeth E Jones; Kristen B Habash; Hiroshi Matsuo; Susanne I Wells
Journal:  Mol Cell Biol       Date:  2006-08-07       Impact factor: 4.272

10.  The flavonoid quercetin transiently inhibits the activity of taxol and nocodazole through interference with the cell cycle.

Authors:  Temesgen Samuel; Khalda Fadlalla; Timothy Turner; Teshome E Yehualaeshet
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.